HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ling Xu Selected Research

Small Interfering RNA (siRNA)

1/2020GLT25D2 Is Critical for Inflammatory Immune Response to Promote Acetaminophen-Induced Hepatotoxicity by Autophagy Pathway.
1/2019The histone chaperone complex FACT promotes proliferative switch of G0 cancer cells.
11/2017Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice.
6/2011Increased expression of cellular repressor of E1A-stimulated gene (CREG) in gastric cancer patients: a mechanism of proliferation and metastasis in cancer.
1/2011Hypoxia induces osteogenesis-related activities and expression of core binding factor α1 in mesenchymal stem cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ling Xu Research Topics

Disease

165Neoplasms (Cancer)
12/2022 - 09/2003
63Breast Neoplasms (Breast Cancer)
08/2022 - 03/2009
53Stomach Neoplasms (Stomach Cancer)
11/2021 - 02/2005
28Neoplasm Metastasis (Metastasis)
11/2022 - 02/2005
27Lung Neoplasms (Lung Cancer)
01/2022 - 09/2003
26Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 11/2011
25Infections
05/2022 - 04/2005
22Hepatocellular Carcinoma (Hepatoma)
05/2020 - 01/2012
21Leukemia
01/2022 - 07/2009
18Osteoporosis
05/2022 - 06/2003
17Carcinogenesis
11/2022 - 12/2011
16Carcinoma (Carcinomatosis)
01/2021 - 02/2005
15Inflammation (Inflammations)
02/2022 - 03/2012
11Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2022 - 02/2011
11Lymphoma (Lymphomas)
01/2022 - 03/2009
10Pain (Aches)
03/2022 - 09/2007
9Dry Eye Syndromes (Dry Eye Syndrome)
03/2022 - 07/2020
9Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2021 - 09/2009
8Colorectal Neoplasms (Colorectal Cancer)
07/2021 - 09/2011
8Disease Progression
05/2021 - 11/2006
7Atherosclerosis
12/2021 - 06/2016
7Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 01/2015
7Liver Neoplasms (Liver Cancer)
01/2020 - 12/2011
6COVID-19
11/2022 - 05/2020
6Wounds and Injuries (Trauma)
01/2021 - 01/2010
6Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 01/2014
6Hypoxia (Hypoxemia)
01/2021 - 03/2005
6Fatigue
01/2020 - 03/2012
6Necrosis
01/2020 - 11/2012
6Fibrosis (Cirrhosis)
01/2019 - 01/2012
6Cancer Pain
07/2015 - 09/2007
5Neurodegenerative Diseases (Neurodegenerative Disease)
02/2022 - 10/2012
5Adenocarcinoma of Lung
03/2021 - 09/2003
5Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 05/2008
5Melanoma (Melanoma, Malignant)
10/2019 - 12/2008
5Type 2 Diabetes Mellitus (MODY)
06/2019 - 10/2014
5Bone Resorption
01/2018 - 09/2009
5Pancreatic Neoplasms (Pancreatic Cancer)
07/2015 - 01/2009
4Insulin Resistance
08/2022 - 01/2019
4Triple Negative Breast Neoplasms
04/2022 - 12/2014

Drug/Important Bio-Agent (IBA)

49Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2003
30Biomarkers (Surrogate Marker)IBA
08/2022 - 01/2013
25Pharmaceutical PreparationsIBA
01/2022 - 09/2008
21MicroRNAs (MicroRNA)IBA
08/2022 - 09/2009
21Messenger RNA (mRNA)IBA
01/2022 - 03/2005
21LigandsIBA
01/2020 - 03/2009
19LipidsIBA
05/2022 - 05/2007
18CytokinesIBA
01/2022 - 08/2004
15Biological ProductsIBA
01/2022 - 02/2005
14DNA (Deoxyribonucleic Acid)IBA
09/2021 - 09/2003
13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 11/2006
10ErbB Receptors (EGF Receptor)IBA
11/2022 - 01/2013
10VaccinesIBA
01/2022 - 11/2002
10AntibodiesIBA
01/2022 - 11/2005
10RNA (Ribonucleic Acid)IBA
10/2021 - 09/2003
9Insulin (Novolin)FDA Link
08/2022 - 05/2007
9Antiviral Agents (Antivirals)IBA
04/2022 - 11/2016
9Hormones (Hormone)IBA
01/2022 - 09/2010
9Cisplatin (Platino)FDA LinkGeneric
01/2020 - 03/2009
8Transcription Factors (Transcription Factor)IBA
12/2022 - 01/2009
8Glucose (Dextrose)FDA LinkGeneric
08/2022 - 08/2012
8human ERBB2 proteinIBA
03/2022 - 12/2012
8Fluorouracil (Carac)FDA LinkGeneric
10/2016 - 05/2006
7T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2022 - 04/2013
7Indicators and Reagents (Reagents)IBA
01/2022 - 03/2011
7Phenobarbital (Luminal)FDA Link
12/2021 - 02/2014
6Carrier Proteins (Binding Protein)IBA
10/2022 - 09/2014
6Trastuzumab (Herceptin)FDA Link
02/2022 - 12/2012
6AntigensIBA
01/2021 - 04/2011
6Long Noncoding RNAIBA
07/2020 - 09/2014
6Epidermal Growth Factor (EGF)IBA
12/2019 - 11/2012
6proanthocyanidinIBA
05/2019 - 05/2008
6UbiquitinIBA
01/2018 - 07/2009
6Therapeutic UsesIBA
01/2016 - 08/2004
6Death Domain ReceptorsIBA
07/2014 - 03/2009
5Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
5Tyrosine Kinase InhibitorsIBA
01/2022 - 01/2013
5oxidized low density lipoproteinIBA
01/2022 - 06/2011
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 03/2015
5Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 01/2012
5CateninsIBA
11/2021 - 01/2013
5CollagenIBA
01/2021 - 12/2011
5Collagen Type I (Type I Collagen)IBA
01/2021 - 09/2009
5Estrogens (Estrogen)FDA Link
08/2020 - 06/2009
5elemeneIBA
04/2020 - 05/2011
5Matrix Metalloproteinases (MMPs)IBA
04/2020 - 08/2004
5Small Interfering RNA (siRNA)IBA
01/2020 - 01/2011
5Cetuximab (Erbitux)FDA Link
01/2020 - 09/2013
5Interleukin-6 (Interleukin 6)IBA
01/2020 - 01/2014
5Concanavalin AIBA
12/2019 - 01/2013
5AnthracyclinesIBA
03/2015 - 03/2009
4ParaffinIBA
11/2022 - 01/2012
4LipopolysaccharidesIBA
02/2022 - 01/2018

Therapy/Procedure

80Therapeutics
04/2022 - 06/2006
37Drug Therapy (Chemotherapy)
12/2022 - 01/2008
24Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 09/2003
22Neoadjuvant Therapy
08/2022 - 03/2009
15Immunotherapy
08/2022 - 12/2008
6Adjuvant Chemotherapy
04/2020 - 03/2010
5Aftercare (After-Treatment)
01/2022 - 01/2013